Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Net Assets

v3.23.1
Consolidated Statements of Changes in Net Assets - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance at beginning of period (in shares) 80,105,999  
Balance at beginning of period $ 609,665 $ 613,170
Shares issued for DRIP (in shares) 564,377 533,062
DRIP participation $ 4,414 $ 4,212
Common stock repurchased (3,985) (3,790)
Net increase resulting from operations 12,231 16,213
Dividends to stockholders $ (14,026) (13,178)
Balance at ending of period (in shares) 80,150,887  
Balance at ending of period $ 608,299 $ 616,627
Common Stock    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance at beginning of period (in shares) 80,105,999 79,826,605
Balance at beginning of period $ 80 $ 80
Shares issued for DRIP (in shares) 564,377 533,062
DRIP participation $ 1  
Common stock repurchased (in shares) (519,489) (489,031)
Common stock repurchased $ (1)  
Balance at ending of period (in shares) 80,150,887 79,870,636
Balance at ending of period $ 80 $ 80
Additional Paid-In Capital    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance at beginning of period 684,165 682,426
DRIP participation 4,413 4,212
Common stock repurchased (3,984) (3,790)
Balance at ending of period 684,594 682,848
Total Overdistributed Earnings    
Increase (Decrease) in Stockholders' Equity [Roll Forward]    
Balance at beginning of period (74,580) (69,336)
Net increase resulting from operations 12,231 16,213
Dividends to stockholders (14,026) (13,178)
Balance at ending of period $ (76,375) $ (66,301)